Archives

Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.

B Osara Health discloses its role as the primary cancer support provider in Swiss Re’s independent Rehabilitation Watch 2025 report, which confirmed a 25:1 return… Login to continue reading Login…

Read MoreSwiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.

Hyperscale Data’s $102 Million in Cash, Restricted Cash, and Bitcoin Holdings Significantly Exceed Current Market Capitalization of Company

B Combined Cash, Restricted Cash, and Bitcoin Holdings Represents Approximately 189.92% of the Company’s Current Market Capitalization LAS VEGAS, April 7, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE… Login to continue reading Login…

Read MoreHyperscale Data’s $102 Million in Cash, Restricted Cash, and Bitcoin Holdings Significantly Exceed Current Market Capitalization of Company